Kentucky Farm Bureau Mutual Insurance Co purchased a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 10,000 shares of the conglomerate’s stock, valued at approximately $1,905,000.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Addison Advisors LLC acquired a new position in Danaher in the 2nd quarter valued at approximately $143,000. Mmbg Investment Advisors CO. acquired a new stake in shares of Danaher during the 2nd quarter valued at $4,117,000. West Family Investments Inc. acquired a new stake in shares of Danaher during the 2nd quarter valued at $230,000. Bantamac Capital LLC purchased a new position in shares of Danaher during the 2nd quarter valued at $762,000. Finally, Knuff & Co LLC purchased a new position in shares of Danaher during the 2nd quarter valued at $1,231,000. 79.05% of the stock is owned by hedge funds and other institutional investors.
Danaher Price Performance
Shares of NYSE:DHR opened at $211.92 on Thursday. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The business has a 50-day moving average of $194.30 and a two-hundred day moving average of $192.44. The stock has a market capitalization of $148.98 billion, a P/E ratio of 37.64, a P/E/G ratio of 2.49 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.
Analysts Set New Price Targets
Several analysts recently issued reports on DHR shares. JPMorgan Chase & Co. cut their price objective on Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Piper Sandler initiated coverage on Danaher in a research note on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price on the stock. Citigroup initiated coverage on Danaher in a research report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price on the stock. HSBC cut their price target on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $240.00 price target on shares of Danaher in a report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
- Five stocks we like better than Danaher
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
